首页> 外文期刊>Analytical chemistry >Mass-Tag Enhanced Immuno-Laser Desorption/Ionization Mass Spectrometry for Sensitive Detection of Intact Protein Antigens
【24h】

Mass-Tag Enhanced Immuno-Laser Desorption/Ionization Mass Spectrometry for Sensitive Detection of Intact Protein Antigens

机译:用于灵敏检测完整蛋白抗原的质量标签增强型免疫激光解吸/电离质谱

获取原文
获取原文并翻译 | 示例
           

摘要

A new read-out method for antibody arrays using laser desorption/ionization-mass spectrometry (LDI-MS) is presented. Small, photocleavable reporter molecules with a defined mass called "mass-tags" are used for detection of immunocaptured proteins from human plasma. Using prostate specific antigen (PSA), a biomarker for prostate cancer, as a model antigen, a high sensitivity generic detection methodology based immunocapture with a primary antibody and with a biotin labeled secondary antibody coupled to mass-tagged avidin is demonstrated. As each secondary antibody can bind several avidin molecules, each having a large number of mass-tags, signal amplification can be achieved. The developed PSA sandwich mass-tag analysis method provided a limit of detection below 200 pg/mL (6 pM) for a 10 mu L plasma sample, Well below the clinically relevant cutoff value of 3-4 ng/mL. This brings the limit of detection (LOD) for detection of intact antigens with matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-MS) down to levels comparable to capture by anti-peptide antibodies selected reaction monitoring (SISCAPA SRM) and enzyme linked immunosorbent assay (ELISA), as 6 pM corresponds to a maximal amount of 60 amol PSA captured on-spot. We :propose the potential use Of LDI (laser desorption/ionization) with mass-tag read-out implemented in a sandwich assay format for low abundant and/or early disease biomarker detection.
机译:提出了一种使用激光解吸/电离质谱(LDI-MS)的抗体阵列读出新方法。具有限定质量的称为“质量标签”的小的可光裂解的报道分子被用于检测人血浆中的免疫捕获蛋白。使用作为前列腺癌生物标志物的前列腺特异性抗原(PSA)作为模型抗原,证明了一种基于高灵敏度通用检测方法的免疫捕获技术,该技术具有一抗和生物素标记的二抗,该二抗与质量标记的抗生物素蛋白偶联。由于每种二抗都可以结合几个具有大量质量标签的亲和素分子,因此可以实现信号放大。所开发的PSA三明治质量标签分析方法为10μL血浆样品提供了低于200 pg / mL(6 pM)的检测限,远低于临床相关的3-4 ng / mL的临界值。这使通过基质辅助激光解吸/电离质谱(MALDI-MS)检测完整抗原的检测限(LOD)降低到可与抗肽抗体选择的反应监测(SISCAPA SRM)和酶捕获相媲美的水平联免疫吸附测定(ELISA),因为6 pM对应于当场捕获的最大60 amol PSA。我们:建议将LDI(激光解吸/电离)与质量标签读取一起以三明治测定形式实施的潜在用途,以进行低丰度和/或早期疾病生物标记检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号